{socialbuttons}
Murray Trial Day 22 November 1, 2011
Dr White Testimony
Flanagan redirect
Flanagan again mentions the variability in the models.
Flanagan shows the Lorazepam model that includes 16 mg oral consumption which is based on 0.0013 mg in the stomach content. If you move the oral intake to 8 AM, the amount of free Lorazepam in the stomach would equal to the 0.008mg found in the autopsy and the concentrations find in blood.
{socialbuttons}
Murray Trial day 21 October 31, 2011
Morning Session
Dr White Testimony
Walgren cross
Dr White is retired after 30 years of clinical care, teaching and research. White says he’s an expert in the use of Propofol, not expert in pharmacokinetics and dynamics modeling. He asks other people to do that such as Dr Shafer.
Walgren asks if there were instances Dr Murray deviated from standards of care on June 25th and the preceding 2 months. Dr White agrees.
Walgren asks what did Dr. White understood from CM’s police interview. White says he understood CM gave 25mg to 50 mg Propofol with 5 CC of lidocaine. Based on interview, could not say how CM administered the drip. White says there could be a number of possibilities about the drip and multiple IV tubes as described by Dr. Shafer is one of the possibilities.
{socialbuttons}
Murray Trial Day 19 October 27, 2011
Morning Session
Dr. Robert Waldman Addiction Specialist
Chernoff Direct
RW states that addiction specialists help patients to stop using alcohol and/or drugs. RW states that if a person came to him looking for help, he would first do an interview and a complete history; repetitive use, age of onset, history of all substances of abuse, history of adverse consequences of use such as legal, social consequences. RW states that a complete medical history but also to focus on the consequences.
{socialbuttons}
Murray Trial Day 20 October 28, 2011
Morning Session
Dr White Testimony
Flanagan Direct
They still discuss the variability between people. Propofol’s effect site is the brain and the amounts in the brain are not measurable in living humans so they use alternative measures such as EEG.
Flanagan shows several papers and graphs that show that levels and effects in patients vary a lot. White explain why models are not representing each and every patient and models are just an average.
{socialbuttons}
Murray Trial Day 18 October 26, 2011
Gerry Causey Testimony
Causey met CM 11 years ago in Las Vegas when he had a heart attack. He was 57 years old and had high blood pressure but didn’t expect to have a heart attack. CM talked to him for a few minutes about the procedure, made sure he understood and made him sign papers. He didn’t want to be sedated for the procedure.
Causey says that he received one stent and kept seeing CM for controls after the procedure and they became friends. Causey says that CM explains everything in simple terms and doesn’t rush the patients. Once Causey spent 4 and half hours in CM’s office.
Causey says CM isn’t greedy because he didn’t charge his deductible. CM told him he would be back and gave him his phone number.